← back to search

Xiaojun Yuan

Ningbo University · CN
Area of research
Information Systems · Neurology
Research interest
Research interests include Medicine, Lymphoma, Internal medicine, Oncology, Anaplastic large-cell lymphoma, and Regimen.
h-index
citations
70
works
17
NIH funding
primary concept
email

Recent publications

The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China
Science China Life Sciences 2025cited by 1position: middledoi
International multidisciplinary consensus recommendations on clinical application of three-dimensional visualization in precision surgery for pediatric liver tumors
HPB 2025cited by 1position: middledoi
Efficacy evaluation of the 2017 protocol by the China Net Childhood Lymphoma in treating early T cell precursors-lymphoblastic lymphoma in pediatric patients
2025cited by 0position: middledoi
Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma
Pediatric Blood & Cancer 2025cited by 0position: middledoi
Clinical characteristics and treatment evaluation of T-cell lymphoblastic lymphoma in Chinese children and adolescents:a multicenter clinical study of China-net childhood lymphoma-lbl-2017
Blood 2025cited by 0position: middledoi
Impact of ALK fusion variants and genetic profiles on prognosis in Chinese pediatric patients with ALK-positive anaplastic large cell lymphoma
Blood 2025cited by 0position: middledoi
[A multicenter study on effect of delayed chemotherapy on prognosis of Burkitt lymphoma in children].
PubMed 2024cited by 2position: middledoi
[Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma].
PubMed 2024cited by 0position: middledoi
<i> <i>NOTCH1</i> </i> gene Fusions Occur Frequently in Refractory or Relapsed (R/R) T-Cell Lymphomablastic Lymphoma
Blood 2024cited by 0position: middledoi
The Mutational Profile and Fusion Landscape of Chinese Pediatric B-Cell Lymphoblastic Lymphoma Patients
Blood 2024cited by 0position: middledoi
A multicenter prospective study on the management of hepatoblastoma in children: a report from the Chinese Children’s Cancer Group
World Journal of Pediatrics 2023cited by 8position: lastdoi
Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma
Blood 2023cited by 1position: middledoi
Clinical Pathology Characteristics of 221 Pediatric Anaplastic Large Cell Lymphoma-3 Years Follow up and Experience from China Net Childhood Lymphoma(CNCL)
Blood 2023cited by 0position: middledoi
[Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
PubMed 2022cited by 6position: middledoi
Treatment barriers and clinical outcome of children with medulloblastoma in China: a report from the Chinese Children’s Cancer Group (CCCG)
Neuro-Oncology Advances 2021cited by 6position: middledoi
[Multicenter clinical study on the diagnosis and treatment of childhood renal tumor].
PubMed 2021cited by 0position: middledoi
Multidisciplinary effort in treating children with hepatoblastoma in China
Cancer Letters 2016cited by 45position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Yonghong Zhang · Hubei University of Medicine3 papers (2024–2025)Ying Liu · New York University3 papers (2024–2025)Qinlong Zheng · Beijing Tongren Hospital3 papers (2024–2025)Ansheng Liu · Dalian Medical University3 papers (2024–2025)Yongjun Fang · Sun Yat-sen University2 papers (2016–2025)Jian Wang · State Key Laboratory of Oral Diseases2 papers (2024–2024)Longhua Sun · National University of Singapore2 papers (2021–2024)Baoxi Zhang · Northwestern Polytechnical University2 papers (2025–2025) · 2 papers (2024–2024)Lian Jiang · Hebei Medical University2 papers (2024–2024) · 2 papers (2024–2025) · 2 papers (2024–2025)Keyan Yang · Shandong University of Technology2 papers (2024–2025) · 2 papers (2024–2025)Yunpeng Dai · Fudan University2 papers (2024–2025) · 2 papers (2024–2024) · 1 papers (2021–2021)Yunqian Fang · China Pharmaceutical University1 papers (2021–2021)Xiaohui Zhang · Anhui Medical University1 papers (2025–2025)Jian Zhou · Shenzhen University Health Science Center1 papers (2025–2025)